Skip to main content
SpringerLink
Log in

Chromosome analyses in patients with myelodysplastic syndromes: Correlation with bone marrow histopathology and prognostic significance

  • Original Articles
  • Published:
Virchows Archiv A Aims and scope Submit manuscript

Summary

Chromosome analyses of bone marrow and peripheral blood cells were performed in a total of 51 patients with myelodysplastic syndromes (MDS) simultaneously with histopathological examination of resinembedded bone marrow biopsies. Diagnosis of MDS was established by histopathology according to the French-American-British (FAB) classification, and reassessed by haematological data and clinical course. Clonal karyotypic changes were found in 30 of the 51 patients (59%): in 15 of 19 (79%) patients with refractory anaemia, 7 of 11 (64%) with refractory anaemia and excess of blasts (RAEB), 6 of 10 (60%) with RAEB in transformation, and 2 of 11 (18%) with chronic myelomonocytic leukaemia. The following three features of the histopathology revealed positive correlations with karyotype abnormalities: all cases of myelofibrosis in MDS (7/51) were accompanied by chromosome aberrations, microforms of megakaryocytes with reduced nuclear lobulation were observed in 18 of 30 cases with karyotype changes, and hypocellularity of haematopoiesis was associated with aberrations of chromosome 7 in 2 of 4 cases. No positive correlations were revealed between abnormal karyotypes and the transformation to acute leukaemia. The survival times were significantly decreased in patients with complex (3 and more) karyotype changes, when compared with patients with single (1–2) chromosome aberrations or normal karyotype, independently of the FAB classification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bennett JM, Catowsky D, Daniel MT, Flandrin G, Gaston DAG, Granlnick HR, Sultan C (1982) The French-American-British (FAB) co-operative Group. Proposals for the classification and staging. Br J Haematol 51:511–530

    Google Scholar 

  • Billström R, Thiede T, Hansen S, Heim S, Kristoffersson U, Mandahl N, Mitelman F (1988) Bone marrow karyotype and prognosis in primary myelodysplastic syndromes. Eur J Haematol 41:341–346

    Google Scholar 

  • Delacretaz F, Schmidt PM, Piguet D, Bachmann F, Costa J (1987) Histopathology of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsie. Am J Clin Pathol 87:180–186

    Google Scholar 

  • Del Potro E, Martinez R, Krsnik I, Lopez Rubino M, Gonzalez Fernandez A, Villegas A (1989) Myelofibrosis in primary myelodysplastic syndromes. Br J Haematol 73:281

    Google Scholar 

  • Dezza L, Cazzola M, Bergamaschi G, Burgio VL, Stella CC, Fenoglio C, Ghizzi A, Nalli G, Sachi F, Ascari E (1983) Myelodysplastic syndrome with monosomy 7 in aduldhood: a distinct preleukemic disorder. Haematologica 68:723–735

    Google Scholar 

  • Gyger M, Infante-Rivard C, D'Angelo G, Forest L, Lussier P (1988) Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes. Am J Hematol 28:13–20

    Google Scholar 

  • Horiike S, Taniwaki M, Misawa S, Abe T (1988) Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 62:1129–1138

    Google Scholar 

  • ISCN (1985) An international system for human cytogenetic nomenclature. Harnden DG, Klinger HP (eds) Published in collaboration with Cytogenet Cell Genet; Karger, Basel

    Google Scholar 

  • Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowly JD (1986) Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 67:1765–1772

    Google Scholar 

  • Kerkhofs H, Hermans J, Haak HL, Leeksma CHW (1987) Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol 65:73–81

    Google Scholar 

  • Lambertenghi-Deliliers G, Orazi A, Luksch R, Annaloro C, Soligo D (1991) Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br J Haematol 78:161–166

    Google Scholar 

  • Mahmood T, Robinson WA, Hamstra RD, Wallner SF (1979) Macrocytic anemia, thrombocytosis and nonlobulated megakaryocytes. The 5q-syndrome, a distinct entity. Am J Med 66:946–950

    Google Scholar 

  • Maschek H, Kaloutsi V, Werner M, Bandecar K, Buhr T, Georgii A (1990) Myelosclerosis in myelodysplastic syndromes (MDS). Retrospective study of 232 patients. Verh Dtsch Ges Pathol 74:144–148

    Google Scholar 

  • Maschek H, Kaloutsi V, Werner M, Bandecar K, Kressel MG, Choritz H, Freund M, Hufnagl D, Georgii A (1992) Myelofibrosis in primary myelodysplastic syndromes (pMDS). A retrospective study of 352 patients. Eur J Haematol 48:208–214

    Google Scholar 

  • Michels SD, Saumur J, Arthur DC, Robison LL, Brunning RD (1989) Refractory anemia with excess of blasts in transformation. Hematologic and clinical study of 52 patients. Cancer 64:2340–2346

    Google Scholar 

  • Moir DJ, Jones PAE, Pearson J, Duncan JR, Cook P, Buckle VJ (1984) A new translocation, t(1;3)(p36;q21) in myelodysplastic disorders. Blood 64:553–555

    Google Scholar 

  • Motoji T, Teramura M, Takahashi M, Oshimi K, Okada M, Kusakabe K, Mizoguchi H (1990) Successful treatment of refractory anemia with high-dose methylprednisolone. Am J Hematol 33:8–12

    Google Scholar 

  • Musilova J, Michaelova K (1988) Chromosome study of 85 patients with myelodysplastic syndrome. Cancer Genet Cytogenet 33:39–50

    Google Scholar 

  • Nand S, Godwin JE (1988) Hypoplastic myelodysplastic syndrome. Cancer 62:958–964

    Google Scholar 

  • Ohyashiki K, Sasao I, Ohyashiki JH, Murakami T, Iwabuchi A, Tauchi T, Saito M, Nakazawa S, Hiromi S, Ebihara Y, Toyama K (1991) Clinical and cytogenetic characteristics of myclodysplastic syndromes developing myelofibrosis. Cancer 68:178–183

    Google Scholar 

  • Pagliuca A, Layton DM, Manoharan A, Gordon S, Green PJ, Mufti GJ (1989) Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. Br J Haematol 71:499–504

    Google Scholar 

  • Rios A, Canizo C, Sanz MA, Vallespi T, Sanz G, Torrabadella M, Gomis F, Ruiz C, San Miguel JF (1990) Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors. Br J Haematol 75:26–33

    Google Scholar 

  • Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes. A multivariable analysis of prognostic factors in 370 patients. Blood 74:395–408

    Google Scholar 

  • Suciu S, Kuse R, Weh HJ, Hossfeld DK (1990) Results of chromosome studies and their relation to morphology, course and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genet Cytogenet 44:15–26

    Google Scholar 

  • Taniwaki M, Horiike S, Inazawa J, Nishida K, Misawa S, Takino T, Abe T (1987) Cytogenetic studies in 37 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis. Jpn J Clin Oncol 17:141–150

    Google Scholar 

  • Third MIC Cooperative Study Group (1988) Morphologic, immunologie and cytogenetic working classification of the primary myelodysplastic syndromes and therapy-related myelodysplasias and leukemias. Cancer Genet Cytogenet 32:1–10

    Google Scholar 

  • Tricot G, Boogaerts MA, De Wolf-Peeters C, Van den Berghe H, Verwilghen RL (1985a) The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations. Br J Haematol 59:659–670

    Google Scholar 

  • Tricot G, Vlietinck R, Boogaerts MA, Hendrickx B, De Wolf-Peeters C, Van den Berghe H, Verwilghen RL (1985b) Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis. Br J Haematol 60:19–32. 430

    Google Scholar 

  • Van den Berghe H, Vermaelen K, Mecucci C, Barbieri D, Tricot G (1985) The 5q-anomaly. Cancer Genet Cell Genet 17:189–225

    Google Scholar 

  • Weh HJ, Calavrezos A, Seeger D, Kuse R, Hossfeld KD (1987) Cytogenetic studies in 69 patients with myelodysplastic syndromes (MDS). Eur J Haematol 38:166–172

    Google Scholar 

  • Yunis JJ, Rydell RE, Oken MM, Arnesen MA, Mayer MG, Lobell M (1986) Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 67:1721–1730

    Google Scholar 

  • Yunis JJ, Lobell M, Arnesen MA, Oken MM, Mayer MG, Rydell RE, Brunning RD (1988) Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br J Haematol 68:189–194

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathologisches Institut der Medizinischen Hochschule Hannover, Konstanty-Gutschow-Strasse 8, W-3000, Hannover 61, Germany

    M. Werner, H. Maschek, V. Kaloutsi, H. Choritz & A. Georgii

Authors
  1. M. Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Maschek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Kaloutsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Choritz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Georgii
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Werner, M., Maschek, H., Kaloutsi, V. et al. Chromosome analyses in patients with myelodysplastic syndromes: Correlation with bone marrow histopathology and prognostic significance. Vichows Archiv A Pathol Anat 421, 47–52 (1992). https://doi.org/10.1007/BF01607138

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01607138

Key words

Search

Navigation